IPOpulse
Sign up
Back to Ticker

Procter & Gamble Health Limited

NSE: PGHL
₹5,135.5
-1.24%EOD · 19 Oct
Market Cap
₹8,525 Cr
52W Range
₹6975 / ₹4707
Volume
5K
59.3% delivery
1Y Return
-17.2%
P/E Ratio
24.2
P/B Ratio
16.5
ROE
61.6%
Debt / Equity
1.77

Quality Score

Durability · Valuation · Momentum — objective math, not advice
C
51/100
Composite score: 40% quality, 30% valuation, 30% momentum
QualityStrong · 75
ValuationGood · 60
MomentumPoor · 10
High ROE (61.6%)
In confirmed downtrend (Stage 4)

Technical Indicators

Full analysis · objective math, not advice
Returns
1D
-1.2%
1W
-1.3%
1M
-5.5%
3M
-25.1%
6M
+2.2%
1Y
-17.2%
Weinstein Stage
Stage 4 — Declining (downtrend)
RSI (14)
39 Neutral
Trend Template
1/7weak
RS vs Nifty (3M)
-19.7pp
Moving Averages (price vs MA)
20-DMA
₹5334
below
50-DMA
₹5572
below
150-DMA
₹5693
below
200-DMA
₹5596
below
From 52W High
-26.4%
From 52W Low
+9.1%
Support (20D)
₹5106
Resistance (20D)
₹5880

Technical indicators are objective calculations from historical EOD prices (RSI, moving averages, Weinstein stage, Minervini trend-template, relative strength). For educational reference only — not a buy/sell recommendation.

News & FilingsGoogle News + BSE

News via Google News · Not verified by IPOpulse · Not investment advice

Community discussion(0)

Sign in to join the discussion.

Sign in

No comments yet — be the first to share your view.